US 9045731
Compositions and methods for improving the functional efficacy of stem cell-derived cardiomyocytes
granted A61KA61K35/12A61K35/545
Quick answer
US patent 9045731 (Compositions and methods for improving the functional efficacy of stem cell-derived cardiomyocytes) held by The Regents of the University of California expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K35/12, A61K35/545, A61P, A61P9/00